News - Latest
98 news items
Anthonius (Ton) de Boer new MEB chairman
Prof. Ton de Boer is to take over as the new chairman of the Medicines Evaluation Board (MEB) as of 1 August 2017. This was ...
MEB starts technical validation of electronic submissions as from 1 June 2017
Submissions concerning human medicinal products must be submitted electronically to the Medicines Evaluation Board (MEB). As from ...
Confirmation of names for influenza strains
The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for the ...
Health Care Inspectorate (IGZ) request to marketing authorisation holders: questionnaire for pharmacovigilance
The Dutch Health Care Inspectorate (IGZ) has developed a risk model for pharmacovigilance to obtain more insight into the risks ...
Policy for the national informed consent marketing authorisation application
A company that wants to apply for a marketing authorisation for a medicinal product that is identical to another product that is ...
One step closer to less animal testing
In the future, a part of animal testing for new medicines will no longer be necessary. In most cases, testing on one species of ...
Retrospective MEB eDay 2017: Change in sight
In order to respond to e-developments, it is important that the information provision by the Medicines Evaluation Board (MEB) can ...
Notification form medicine shortages and defects now also in English
As of today, the notification form of the Medicine shortages and defects notification centre is now also available in English. ...
Science Day 2017 - Generic drugs in society: the regulator’s dilemma
Trust, costs, safety and proper information are the words that regularly recurred during the 6th Science Day of the Medicines ...
The Netherlands a candidate for future EMA location
The Netherlands has submitted its candidacy as the country of choice for housing the European Medicines Agency (EMA). The EMA is ...